<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="26634">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01770015</url>
  </required_header>
  <id_info>
    <org_study_id>2011-A00767-34</org_study_id>
    <nct_id>NCT01770015</nct_id>
  </id_info>
  <brief_title>Bronchial Colonization With Fungi and Late Respiratory Acquired Pneumonia</brief_title>
  <acronym>CBF et PAVMt</acronym>
  <official_title>Study of the Impact of Bronchial Colonization With Fungi in the Occurrence of Late Ventilator Acquired Pneumonia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <authority>France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ventilator acquired pneumonia (VAP) are severe nosocomial infections. On the other side,
      bronchial fungi colonization is commonly observed in ICU; therefore, the investigators
      propose to study the role of bronchial fungi colonization on the occurrence of VAP taking
      into account the immune status of the patient and the antibiotic and antifungal treatments
      he has received.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Anticipated">November 2014</completion_date>
  <primary_completion_date type="Anticipated">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Onset of a late ventilator acquired pneumonia (VAP)</measure>
    <time_frame>Participants will be followed for the duration of mechanical ventilation, an expected time frame that can go from 5 days to up to 8 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Onset of a pseudomonas aeruginosa associated VAP</measure>
    <time_frame>Participants will be followed for the duration of mechanical ventilation, an expected time frame that can go from 5 days to up to 8 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Onset of late ventilator associated pneumonia associated to staphylococcus aureus</measure>
    <time_frame>Participants will be followed for the duration of mechanical ventilation, an expected time frame that can go from 5 days to up to 8 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Ventilator Acquired Pneumonia</condition>
  <arm_group>
    <arm_group_label>ventilated patient</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>biological sampling</intervention_name>
    <description>cutaneous, rectal, nose and mouth swabs to identify potential fungi colonization</description>
    <arm_group_label>ventilated patient</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>sampling blood</intervention_name>
    <description>HLA DR antigen, cytokines (IL 6 and 10), B-glucan</description>
    <arm_group_label>ventilated patient</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>endotracheal aspiration</intervention_name>
    <description>fungi and bacteria endotracheal aspiration</description>
    <arm_group_label>ventilated patient</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient ventilated for at least 5 days

        Exclusion Criteria:

          -  invasive infection Candida sp defined by : candidemia, isolation of Candida from a
             normally sterile site, candida pneumoniae.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>TIMSIT Jean-François, PU/PH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Grenoble</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Timsit Jean-Francois, PU/PH</last_name>
    <phone>0476768779</phone>
    <email>jftimsit@chu-grenoble.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital of Grenoble</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>TIMSIT Jean-Francois, PU/PH</last_name>
      <phone>0476768779</phone>
      <email>JFTimsit@chu-grenoble.fr</email>
    </contact>
    <contact_backup>
      <last_name>TOURNEGROS caroline, ARC</last_name>
      <phone>0476767109</phone>
      <email>CTournegros@chu-grenoble.fr</email>
    </contact_backup>
    <investigator>
      <last_name>HAMIDFAR Rebecca, PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>PELLOUX Hervé, PU/PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>CORNET Muriel, PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>November 7, 2013</lastchanged_date>
  <firstreceived_date>June 21, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Grenoble</investigator_affiliation>
    <investigator_full_name>AdministrateurDRC</investigator_full_name>
    <investigator_title>Pr JF TIMSIT</investigator_title>
  </responsible_party>
  <keyword>patient ventilated for at least five days</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Pneumonia, Ventilator-Associated</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
